Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1972 Nov;46(3):480–487. doi: 10.1111/j.1476-5381.1972.tb08145.x

Inhibition by metrifonate and dichlorvos of cholinesterases in schistosomes

E Bueding, C L Liu, S H Rogers
PMCID: PMC1666567  PMID: 4656609

Abstract

1. No species differences between Schistosoma haematobium and Schistosoma mansoni were detected when the I50 of metrifonate for the acetylcholinesterases (AChE) and the cholinesterases (ChE) of these two trematodes were determined in isolated enzyme preparations or following exposure of the intact worms to this drug in vitro.

2. S. haematobium appeared to be more affected by AChE inhibition because, after administration of metrifonate to hamsters, a hepatic shift of the parasites was observed with a dose of metrifonate (150 mg (0·6 mmol) per kg) which produced no shift of S. mansoni, although AChE inhibition was comparable in both species.

3. Administration of a possible metabolite of metrifonate, dichlorvos, to hamsters resulted in a greater inhibition of AChE and ChE activities of S. haematobium than those of S. mansoni. Furthermore, when schistosomes were incubated with dichlorvos, inhibition of AChE activity of female S. haematobium was significantly greater (P<0·005) than that of both sexes of S. mansoni and of male S. haematobium.

4. The discrepancy between the lack of a significant chemotherapeutic effect of metrifonate in hamsters infected with S. haematobium and the clinical results obtained with this organophosphorus compound in human schistosomiasis haematobium is discussed, and the need to conduct similar studies in primates is pointed out.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdalla A., Saif M., Taha A., Ashmawy H., Tawfik J., Abdel-Fattah F., Sabet S., Abdel-Meguid M. Evaluation of an organo-phosphorus compound, Dipterex in the treatment of bilharziasis. J Egypt Med Assoc. 1965;48(4):262–273. [PubMed] [Google Scholar]
  2. BEHEYT P., LEBRUN A., CERF J., DIERICKX J., DEGROOTE V. [Study of the toxicity to humans of an organophosphorated insecticide]. Bull World Health Organ. 1961;24:465–473. [PMC free article] [PubMed] [Google Scholar]
  3. BUEDING E. Acetylcholinesterase activity of Schistosoma mansoni. Br J Pharmacol Chemother. 1952 Dec;7(4):563–566. doi: 10.1111/j.1476-5381.1952.tb00722.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BUTTLE G. A., KHAYYAL M. T. Rapid hepatic shift of worms in mice infected with Schistosoma mansoni after a single injection of tartar emetic. Nature. 1962 May 26;194:780–781. doi: 10.1038/194780b0. [DOI] [PubMed] [Google Scholar]
  5. Barker L. R., Bueding E., Timms A. R. The possible role of acetylcholine in Schistosoma mansoni. Br J Pharmacol Chemother. 1966 Mar;26(3):656–665. doi: 10.1111/j.1476-5381.1966.tb01845.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bueding E., Fisher J. Factors affecting the inhibition of phosphofructokinase activity of Schistosoma mansoni by trivalent organic antimonials. Biochem Pharmacol. 1966 Aug;15(8):1197–1211. doi: 10.1016/0006-2952(66)90285-1. [DOI] [PubMed] [Google Scholar]
  7. Bueding E., Schiller E. L., Bourgeois J. G. Some physiological, biochemical, and morphologic effects of tris (p-aminophenyl) carbonium salts (TAC) on Schistosoma mansoni. Am J Trop Med Hyg. 1967 Jul;16(4):500–515. doi: 10.4269/ajtmh.1967.16.500. [DOI] [PubMed] [Google Scholar]
  8. CERF J., LEBRUN A., DIERICHX J. A new approach to helminthiasis control: the use of an organophosphorous compound. Am J Trop Med Hyg. 1962 Jul;11:514–517. doi: 10.4269/ajtmh.1962.11.514. [DOI] [PubMed] [Google Scholar]
  9. Clive D., Flamm W. G., Machesko M. R. Mutagenicity of hycanthone in mammalian cells. Mutat Res. 1972 Feb;14(2):262–264. doi: 10.1016/0027-5107(72)90055-3. [DOI] [PubMed] [Google Scholar]
  10. Davis A., Bailey D. R. Metrifonate in urinary schistosomiasis. Bull World Health Organ. 1969;41(2):209–224. [PMC free article] [PubMed] [Google Scholar]
  11. ELLMAN G. L., COURTNEY K. D., ANDRES V., Jr, FEATHER-STONE R. M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961 Jul;7:88–95. doi: 10.1016/0006-2952(61)90145-9. [DOI] [PubMed] [Google Scholar]
  12. Ferone R., Burchall J. J., Hitchings G. H. Plasmodium berghei dihydrofolate reductase. Isolation, properties, and inhibition by antifolates. Mol Pharmacol. 1969 Jan;5(1):49–59. [PubMed] [Google Scholar]
  13. Forsyth D. M., Rashid C. Treatment of urinary schistosomiasis. Practice and theory. Lancet. 1967 Jan 21;1(7482):130–133. doi: 10.1016/s0140-6736(67)91034-3. [DOI] [PubMed] [Google Scholar]
  14. Hanna S., Basmy K., Selim O., Shoeb S. M., Awny A. Y. Effects of administration of an organo-phosphorus compound as an antibilharzial agent, with special reference to plasma cholinesterase. Br Med J. 1966 Jun 4;1(5500):1390–1392. doi: 10.1136/bmj.1.5500.1390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hartman P. E., Levine K., Hartman Z., Berger H. Hycanthone: a frameshift mutagen. Science. 1971 Jun 4;172(3987):1058–1060. doi: 10.1126/science.172.3987.1058. [DOI] [PubMed] [Google Scholar]
  16. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  17. MANSOUR T. E., BUEDING E. The actions of antimonials on glycolytic enzymes of Schistosoma mansoni. Br J Pharmacol Chemother. 1954 Dec;9(4):459–462. doi: 10.1111/j.1476-5381.1954.tb00861.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. STANDEN O. D. Experimental schistosomiasis. III. Chemotherapy and mode of drug action. Ann Trop Med Parasitol. 1953 Mar;47(1):26–43. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES